Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...

Maryland resident James Riordan assumed the mole on his cheek was harmless until his wife pointed it out and encouraged him to have it examined. "I pointed it out to my dermatologist, and she probably ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

What began as a casually shared image on social media soon turned into a serious health discussion after a woman posted a photograph of faint black lines on her thumb and toe nails, prompting ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, hematology, and infectious & inflammatory diseases, announced today ...

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

The "ugly duckling" sign, a dermatological clue, identifies moles that stand out from others in size, shape, color, or ...